Cargando…
Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis
BACKGROUND: Most patients with autoimmune hepatitis respond to standard treatment with steroids and azathioprine. While the disease is usually fatal if untreated, patients who respond well to therapy have an excellent prognosis. Nevertheless, second-line treatment is necessary in approximately 20% o...
Autores principales: | Kolev, Mirjam, Diem, Stefan, Diem, Lara, Rodrigues, Susana G., Berzigotti, Annalisa, Stirnimann, Guido, Semmo, Nasser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702977/ https://www.ncbi.nlm.nih.gov/pubmed/36451933 http://dx.doi.org/10.1016/j.jtauto.2022.100172 |
Ejemplares similares
-
Increased T- and B-cells associated with the phenotype of autoimmune limbic encephalitis with mainly memory dysfunction
por: Hansen, Niels, et al.
Publicado: (2022) -
An update on epigenetic regulation in autoimmune diseases
por: Mei, Xiaole, et al.
Publicado: (2022) -
COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies
por: Gragnani, Laura, et al.
Publicado: (2022) -
Anti-Sm antibodies in the classification criteria of systemic lupus erythematosus
por: van Beers, Joyce J.B.C., et al.
Publicado: (2022) -
Association of anti-SARS-COV-2 vaccine with increased incidence of myositis-related anti-RNA-synthetases auto-antibodies
por: García-Bravo, Laura, et al.
Publicado: (2022)